Fingerprint
Dive into the research topics of 'Overview of the patent expiry of (non-)tyrosine kinase inhibitors approved for clinical use in the EU and the US'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Overview of the patent expiry of (non-)tyrosine kinase inhibitors approved for clinical use in the EU and the US
Subramanian Venkatesan, Martine Lamfers, Sieger Leenstra, Arnold G. Vulto*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
7
Citations
(Scopus)